BCM
Bayesian Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,815
| Closed | -$480K | – | 606 |
|
|
2019
Q1 | $480K | Sell |
3,815
-2,000
| -34% | -$252K | 0.09% | 300 |
|
|
2018
Q4 | $789K | Buy |
5,815
+1,466
| +34% | +$199K | 0.16% | 200 |
|
|
2018
Q3 | $1.19M | Buy |
4,349
+3,107
| +250% | +$853K | 0.2% | 139 |
|
|
2018
Q2 | $257K | Buy |
+1,242
| New | +$257K | 0.06% | 446 |
|
|
2017
Q4 | – | Sell |
-4,200
| Closed | -$572K | – | 641 |
|
|
2017
Q3 | $572K | Buy |
+4,200
| New | +$572K | 0.14% | 243 |
|